Skip to main content

Table 9 Estimates of funds

From: Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis

Medication methodMinimum Dose x Minimum TimeRMB (yuan)Maximum Dose x Maximum TimeRMB (yuan)
Inhalation250μg qd × 14 weeks, 4 days-on, 4 days-off15,190500μg bid*68 weeks344,306
Subcutaneous injection9μg/kg/day*12 weeks32,81118μg/kg/d*52 weeks284,357
This method75μg qd*6 months7324150μg qd*6 months13,020